The different level of MR activation and therapeutic inhibition, as well as mean aldosterone concentrations or prolonged effects of aldosterone in PA patients in the absence of chronic kidney disease might play a role on calcification propensity. This evidence concerns the gene NR3C2 and chronic kidney disease.